Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Méndez‐Blanco, Flavia Fondevila, Andrés García‐Palomo, et al.
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 10, pp. 1-9
Open Access | Times Cited: 278

Showing 1-25 of 278 citing articles:

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang, Ziyi Chen, Wenling Zhang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 770
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Jiao Feng, Jingjing Li, Liwei Wu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 478
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 328
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
José J.G. Marı́n, Rocı́o I.R. Macı́as, María J. Monte, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1663-1663
Open Access | Times Cited: 156
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation
Sunbin Ling, Qiaonan Shan, Qifan Zhan, et al.
Gut (2019) Vol. 69, Iss. 7, pp. 1322-1334
Closed Access | Times Cited: 150
Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer
Heidie Frisco Cabanos, Aaron N. Hata
Cancers (2021) Vol. 13, Iss. 11, pp. 2666-2666
Open Access | Times Cited: 132
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
Weihao Li, Chi Zhou, Long Yu, et al.
Autophagy (2023) Vol. 20, Iss. 1, pp. 114-130
Open Access | Times Cited: 121
Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options
Zuzanna Sas, Ewa Cendrowicz, Isabel Weinhäuser, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3778-3778
Open Access | Times Cited: 119
Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
Yan Li, Wenjuan Yang, Yuanyuan Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 89
Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 22
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Hypoxia-inducible factors and innate immunity in liver cancer
Vincent Wai‐Hin Yuen, Carmen Chak‐Lui Wong
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5052-5062
Open Access | Times Cited: 139
Nanoparticle Delivery of MnO2 and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma
Chih-Chun Chang, Trinh Kieu Dinh, Yi-An Lee, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 40, pp. 44407-44419
Closed Access | Times Cited: 95
Endoplasmic reticulum stress and protein degradation in chronic liver disease
Siwei Xia, Zhimin Wang, Sumin Sun, et al.
Pharmacological Research (2020) Vol. 161, pp. 105218-105218
Closed Access | Times Cited: 95
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma
Junjie Xu, Lin Ji, Yeling Ruan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 90
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
Jiao Feng, Liwei Wu, Jie Ji, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 87
The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
Zhongqiang Zhang, Xiao Tan, Jing Luo, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 80
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
Paula Fernández‐Palanca, Flavia Fondevila, Carolina Méndez‐Blanco, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 2875-2875
Open Access | Times Cited: 79
The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
Yu Huang, Wenhao Ge, Jiarong Zhou, et al.
Journal of Cancer (2021) Vol. 12, Iss. 5, pp. 1284-1294
Open Access | Times Cited: 77
The roles and mechanisms of hypoxia in liver fibrosis
Jingyao Cai, Min Hu, Zhiyang Chen, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 77
miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
Lin Ji, Zhongjie Lin, Zhe Wan, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 71
New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Yu He, Luo Yang, Lan Huang, et al.
Pharmacological Research (2021) Vol. 170, pp. 105732-105732
Open Access | Times Cited: 60
PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis
Yu He, Xixi Wang, Weiliang Lu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 47
RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC
Yichi Chen, Haitao Shang, Chunyue Wang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 105-123
Open Access | Times Cited: 39
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez–Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top